|
Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, May 12, 2016 ) The report provides comprehensive information on the therapeutics under development for Chronic Cough, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Chronic Cough and features dormant and discontinued projects.
This H1 2016 Global Chronic Cough Healthcare Industry Development Analysis report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Publisher's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.
Other Key Points in Report:
- The report provides a snapshot of the global therapeutic landscape of Chronic Cough
- The report reviews pipeline therapeutics for Chronic Cough by companies and universities/research institutes based on information derived from company and industry-specific sources
- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
- The report reviews key players involved Chronic Cough therapeutics and enlists all their major and minor projects
- The report assesses Chronic Cough therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
Inquire before Purchasing Report @ http://www.reportsweb.com/inquiry&RW0001236078/buying
Reasons to Buy
- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of therapeutics under development for Chronic Cough
- Identify potential new clients or partners in the target demographic
- Develop strategic initiatives by understanding the focus areas of leading companies
- Plan mergers and acquisitions effectively by identifying key players and it's most promising pipeline therapeutics
- Devise corrective measures for pipeline projects by understanding Chronic Cough pipeline depth and focus of Indication therapeutics
Ask for Sample Report @ http://www.reportsweb.com/inquiry&RW0001236078/sample
Table of Content: An Overview
Introduction 6
Publisher Report Coverage 6
Chronic Cough Overview 7
Therapeutics Development 8
Pipeline Products for Chronic Cough - Overview 8
Pipeline Products for Chronic Cough - Comparative Analysis 9
Chronic Cough - Therapeutics under Development by Companies 10
Chronic Cough - Therapeutics under Investigation by Universities/Institutes 11
Chronic Cough - Pipeline Products Glance 12
Clinical Stage Products 12
Early Stage Products 13
Chronic Cough - Products under Development by Companies 14
Chronic Cough - Products under Investigation by Universities/Institutes 15
Chronic Cough - Companies Involved in Therapeutics Development 16
Afferent Pharmaceuticals, Inc. 16
Ario Pharma Ltd 17
AstraZeneca Plc 18
Conrig Pharma ApS 19
GlaxoSmithKline Plc 20
Glenmark Pharmaceuticals Ltd. 21
GW Pharmaceuticals Plc 22
NeRRe Therapeutics Ltd 23
Patara Pharma, Inc. 24
Ask for Discount on Report @ http://www.reportsweb.com/inquiry&RW0001236077/discount
Chronic Cough - Therapeutics Assessment 25
Assessment by Monotherapy Products 25
Assessment by Target 26
Assessment by Mechanism of Action 28
Assessment by Route of Administration 30
Assessment by Molecule Type 32
Drug Profiles 33
AF-219 - Drug Profile 33
Product Description 33
Mechanism of Action 33
R&D Progress 33
cromolyn sodium - Drug Profile 35
Product Description 35
Mechanism of Action 35
R&D Progress 35
GRC-17536 - Drug Profile 36
Product Description 36
Mechanism of Action 36
R&D Progress 36
GSK-2339345 - Drug Profile 37
Product Description 37
Mechanism of Action 37
R&D Progress 37
Purchase Complete Report @ http://www.reportsweb.com/buy&RW0001236077/buy/2000
About ReportsWeb:
ReportsWeb.com is a one stop shop of market research reports and solutions to various companies across the globe. We help our clients in their decision support system by helping them choose most relevant and cost effective research reports and solutions from various publishers. We provide best in class customer service and our customer support team is always available to help you on your research queries.
Contact Us:
Email: sales@reportsweb.com
Call: +1-646-491-9876
ReportsWeb.com
Priya Sisodia
+1-646-491-9876
sales@reportsweb.com
Source: EmailWire.Com 
Source: EmailWire.com
|
|
|
|
